SPONSOR
European Institute of Oncology
Total Trials
9
Recruiting
9
Phases
Phase 2
Conditions studied: Breast CancerBreast Cancer InvasiveNode Positive Breast CancerTriple Negative Breast CancerMelanoma (Skin Cancer)Lung Cancer (NSCLC)NSCLCLung Cancer (Diagnosis)Neuroendocrine NeoplasmAdenocarcinoma
European Institute of Oncology is a clinical research sponsor with 9 registered studies on ClinicalTrials.gov, of which 9 are actively recruiting participants. Research covers conditions including Breast Cancer, Breast Cancer Invasive, Node Positive Breast Cancer, Triple Negative Breast Cancer.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — European Institute of Oncology
How many clinical trials has European Institute of Oncology sponsored?
ClinicalMetric currently tracks 9 clinical trials sponsored by European Institute of Oncology, of which 9 are actively recruiting participants. These trials cover conditions including Breast Cancer, Breast Cancer Invasive, Node Positive Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does European Institute of Oncology research focus on?
European Institute of Oncology clinical trials span Breast Cancer, Breast Cancer Invasive, Node Positive Breast Cancer, Triple Negative Breast Cancer, Melanoma (Skin Cancer), and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a European Institute of Oncology clinical trial?
To participate in a European Institute of Oncology trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all European Institute of Oncology trials with current recruitment status updated daily.
Clinical Trials by European Institute of Oncology
NCT06703567
Recruiting
IMproving PAtient UndeRstanding of GEP TEst Results: Phase 4
Breast Cancer
NCT06790264
Recruiting
Exploring the Tumor Micro-Environment with 68Ga-FAPi-46 PET/CT in Breast Cancer
Breast Cancer Invasive
NCT06690840 Phase 2
Recruiting
Atezolizumab and Chemotherapy Treatment as T-cell Activators in Metastatic Triple Negative Breast Cancer Patients
Triple Negative Breast Cancer
NCT06300125
Recruiting
Percutaneous Cryoablation of Low-risk Early Breast Cancer
Breast Cancer
NCT07691255
Recruiting
MELanoma Brain Metastasis Treated With CYberknife
Melanoma (Skin Cancer)
NCT07790406
Recruiting
Surgical Outcome Of da Vinci Single-port Surgical System In Lung Cancer
Lung Cancer (NSCLC)
NCT07325864
Recruiting
Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site
NSCLC
NCT06337760
Recruiting
YOUNg Adults With Gastro-inteSTinal (GI) and nEuroendocrine canceRs.
Neuroendocrine Neoplasm
NCT05860361
Recruiting
Advanced Proton Therapy Approaches: a Multicenter High-quality Data Registry
Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology